loader image
INVEST IN LONGEVITY
INVEST IN LONGEVITY

INVEST INTO LONGEVITY

Full Range of Living Conditions for Longevity
We know How To Improve Your Life Now
Become part of a decentralized ecosystem
GLOBAL LONGEVITY METAVERSE

[/vc_column_inner]

TRADE GLOBAL LONGEVITY METAVERSE TOKENS ON:

Trade GLM
Trade GLMV
LEGAL DOCUMENTS
WHITEPAPER
ONE PAGER & MVP
LEGAL NATURE OF TOKEN
KYC PROCEDURE
ABOUT PROJECT
Global Longevity Metaverse creates a high-tech space for millions of scientists, doctors and patients, which provides people with the most advanced technologies to preserve their health, prolong life on the terms of high-quality longevity.
Global Longevity Metaverse provides an opportunity for every person in the world, regardless of place of residence, social status and financial potential, to control their health and vital diagnostic indicators. Active high-quality longevity depends not only on high-quality and timely treatment, but also on the prevention of diseases with the help of associated artificial intelligence, which fixes the slightest deviations from the norm and warns about it in a timely manner.
Global Longevity Metaverse is supported by high-tech hardware, a unique network, the necessary computing power, a Global Longevity virtual platform with appropriate tools and exchange standards, a specially created payment system with GLM and GLVM cryptocurrencies, serving all the necessary content, assets and services.
Global Longevity Metaverse is a decentralized, scalable ecosystem that creates a full spectrum of living conditions for quality longevity. It uses all the latest achievements of world science and works on the IT platform for the personalized management of life span based on blockchain, neural networks and machine learning.
GLM and GLVM is generated by Global Longevity Metaverse and provides its owners with access to the company’s current and future services. Global Longevity Metaverse embodies the best technologies and years of experience in the longevity market.

GLM & GLVM Gives You Power, Utility, and Transparency

1. Vote for Projects you Want Global Longevity Metaverse to Fund
2. Vote for Proposals, Allocations, and more
3. Submit Ideas and Proposals
4. Transfer your Data
5. Utility to Access Global Longevity Metaverse, DeSci,
6. Participate in Projects in our Ecosystem
7. Understanding of your health and its value

Our Mission

  • Tackling aging with the power of a global community
  • Radically extend healthy human lifespan by funding cutting-edge aging research and democratizing ownership of Intellectual Property
Become part of a decentralized ecosystem

GLOBAL LONGEVITY METAVERSE

0
5

CONTINENTS

0
18

COUNTRIES

0
256

INVESTORS

0
36

PARTNERS

0
122

EMPLOYEES

Image
Ukraine
Singapore
Germany
Georgia
Israel
China
Mexico
Sri Lanka
Brazil
Turkey
Ecuador
Peru
South Africa
Argentina
Vietnam
India
Costa Rica
Australia

DO NOT BE A GUEST IN LIFE

BECOME HER HOST!

START YOUR JOURNEY TO GLOBAL LONGEVITY

I decided to live forever. And so far everything goes well.

Unknown Author

THAT CAN BE PURCHASED FOR LONGEVITY

Global Longevity Labs

Our mission is to restore cell health and resilience through cell rejuvenationto reverse disease, injury and the disabilitiesthat can occur throughout life.

Learn More

Diagnosis and Treatment

A complete diagnosis of the body means a comprehensive examination, which is carried out with the help of special devices and through the delivery of various tests. The data obtained allow us to make a complete picture of the state of human health, its internal organs and new formations, both benign and malignant.

Learn More

Global Longevity Science Foundation

Adding Years to Our Lives and Life to Our Years Global Longevity Science Foundation (GLSF) is a global nonprofit working diligently to prevent chronic and age-related disease, aiming to extend the healthy human lifespan by funding critical scientific research.

Learn More

Pharmacological Products

This industry is related to research, development, mass production, market research and distribution of medicines, mainly intended for the prevention, relief and treatment of diseases. Currently, the pharmaceutical industry is one of the most successful industries.

Learn More

Organic Food Products for GLOBAL LONGEVITY

All over the world, the production of organic food is booming. This food contains on average 10–50% more vitamins, minerals and other nutrients compared to products produced by modern technologies. Organic food improves health, boosts immunity, and especially it is useful for children, pregnant women and nursing mothers.

Learn More
TOKEN

Name:

GLOBAL LONGEVITY METAVERSE

Ticker:

GLM

Platform:

Solana

Token Type:

Utility

Hard Cap:

1.000.000.000 GLM

PERCENTAGE OF TOKENS DISTRIBUTION

ALLOCATING AND USING FUNDS

ROADMAP
gl-logo-512

Establishing new biotech research facilities. Development of a new biotech laboratory complex in Shenzhen.

gl-logo-512

Listing of Global Longevity Metaverse tokens on new world exchanges.

gl-logo-512

Development of the main directions of scientific research work of the Global Longevity Metaverse and the beginning of the work of the International Clinic of Global Longevity Metaverse.

GLM_university_logo_360

Development and Improvement of GLOBAL LONGEVITY METAVERSE University.

GLM_television_logo_360

Development and Improvement of GLOBAL LONGEVITY METAVERSE Television.

TEAM & ADVISORS
gl-logo-512

Global Longevity Science Foundation (GLSF)

gl-logo-512

Supervisory Board

gl-logo-512

Department of Biotechnology Research

gl-logo-512

Department of Pharmacology

gl-logo-512

Public Relations Office

salvador

GEOVANNI TEVEZ

CEO (Chief Executive Officer), CEO Global Longevity Metaverse

croatia

TAMARA DANCEVIC

CFO (Chief financial officer)

china

Jīnlóng Xiàng

CLO (Chief Legal Officer)

Manager of legal informatization, director of legislative technologies. Advisor to the corporation, executive of the highest rank, responsible for the legal support of contracts, expert in cryptocurrency legislation.

india

Champ Janadar

CMO (Chief Marketing Officer)

Consultant in marketing and marketing strategy of the enterprise, manages the work of the marketing service of the enterprise.

laos

Guāngmíng Bō

CAO (Chief advertising officer)

singapore_400

Soeharto Lee

Professor of Medicine, Longevity Technology Expert

china_400

LIU JUAN

Professor of Medicine

sri_lanka_400

DEEPAKA ABEESEKARA

Doctor of Medicine

brazil_400

JOAQUIM SILVA

Doctor of Medicine

mexico_400

ALBERTO RODRIGUEZ

Doctor of Medicine

turkey_400

METIN OZTURK

Doctor of Medicine

australia_400

PETER WOLLY

Doctor of Medicine

costa_rica_400

DIEGO MARTINEZ

Doctor of Medicine

india_400

RAJ AHIRWAR

Doctor of Medicine

vietnam_400

LUONG NGUYEN

Doctor of Medicine

argentina_400

MARIA VICTORIA ROJAS

Doctor of Medicine

south_africa_400

ADISA NGCOBA

Doctor of Medicine

peru_400

TERESA GUEVARA

Doctor of Medicine

singapore_400

TAN YEE POH

Doctor of Medicine

ecuador_400

NADIA JIMENEZ

Doctor of Medicine

MAKE A STEP TOWARDS TO

LONGEVITY!

START YOUR JOURNEY TO GLOBAL LONGEVITY
PARTNERS, NEWS & PUBLICATIONS
GET IN TOUCH WITH US

     

    Global Longevity Disclaimer

    Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

    Potential investors should note that participation in the Global Longevity Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

    Potential investors should note that participation in the Global Longevity project Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Global Longevity project. Investors should make their decision to buy or to subscribe to Global Longevity project.

    Investors are furthermore advised to consult their bank or financial adviser before making any investment decision. This publication may contain specific forward-looking statements, e.g. statements including terms like “believe”, assume”, “expect”, “forecast”, “project”, “may”, “could”, “might”, “will” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements.

    Against the background of these uncertainties, readers should not rely on forward-looking statements. Global Longevity project assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction.

    The Global Longevity project are not for sale and distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia), Canada, Japan, Australia, North Korea, Iran, Myanmar, Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde, Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction into which the same would be unlawful.

    This announcement does not constitute or form a part of any offer or solicitation to purchase, subscribe for or otherwise acquire securities in the United States, Canada, Japan, Australia, North Korea, Iran, Myanmar,Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde,Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction in which such an offer or solicitation is unlawful.

    The Global Longevity project will not be registered under the US Securities Act of 1933, as amended or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States.

    The Global Longevity project have not been approved or disapproved by the US Securities and Exchange Commission, any state’s securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Global Longevity project or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom.

    This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The Global Longevity project are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such the Global Longevity project will be engaged in only with, relevant persons.

    Any person who is not a relevant person should not act or rely on this document or any of its contents. Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”) is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive.

    I agree What is Disclaimer?